Prestige Consumer Healthcare Inc.

NYSE PBH

Prestige Consumer Healthcare Inc. Market Capitalization on January 14, 2025: USD 3.74 B

Prestige Consumer Healthcare Inc. Market Capitalization is USD 3.74 B on January 14, 2025, a 28.10% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Prestige Consumer Healthcare Inc. 52-week high Market Capitalization is USD 4.24 B on December 04, 2024, which is 13.25% above the current Market Capitalization.
  • Prestige Consumer Healthcare Inc. 52-week low Market Capitalization is USD 2.91 B on January 18, 2024, which is -22.32% below the current Market Capitalization.
  • Prestige Consumer Healthcare Inc. average Market Capitalization for the last 52 weeks is USD 3.53 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NYSE: PBH

Prestige Consumer Healthcare Inc.

CEO Mr. Ronald M. Lombardi CPA
IPO Date Feb. 10, 2005
Location United States
Headquarters 660 White Plains Road
Employees 570
Sector Health Care
Industries
Description

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Similar companies

RGC

Regencell Bioscience Holdings Limited

USD 4.86

-4.71%

PCRX

Pacira BioSciences, Inc.

USD 20.55

-2.74%

PAHC

Phibro Animal Health Corporation

USD 20.28

0.05%

ANIP

ANI Pharmaceuticals, Inc.

USD 54.16

0.43%

SUPN

Supernus Pharmaceuticals, Inc.

USD 37.82

0.66%

COLL

Collegium Pharmaceutical, Inc.

USD 33.18

-1.80%

AMPH

Amphastar Pharmaceuticals, Inc.

USD 38.48

1.48%

StockViz Staff

January 15, 2025

Any question? Send us an email